Alcon (ALC) return on equity (ROE)

Return on equity · fiscal 2025
4.4%

Alcon (ALC) earned a return on equity of 4.4% in fiscal 2025 (the year ended December 31, 2025). That is 0.3 percentage points lower than the 4.7% of fiscal 2024. Figures as of 17 Nov 2026, 19:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
4.4%
Change on fiscal 2024
−0.3 pts
Highest on record
47.0%fiscal 2007
Lowest on record
1.7%fiscal 2022
Fiscal years on record
82007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Alcon return on equity (ROE), in more detail

Across the 8 fiscal years on record (2007–2025), the highest was 47.0% in fiscal 2007 and the lowest 1.7% in fiscal 2022. The fiscal 2025 figure is higher than in 14% of the 7 earlier fiscal years on record, whose median is 30.5%.

History · 8 fiscal years

Return on equity by fiscal year

Alcon return on equity (ROE), year by year

Alcon (ALC) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20254.4% 0.3 pts down
20244.7% 0.0 pts
20234.7% 3.0 pts up
20221.7%—
201030.5% 3.5 pts down
200934.0% 9.6 pts down
200843.6% 3.4 pts down
200747.0%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Alcon and comparable companies
CompanyReturn on equityFiscal year
Biogen BIIB7.1%2025
GE HealthCare Technologies GEHC20.1%2025
Alcon ALC4.4%2025
Mettler-Toledo International MTD3519.1%2022
Centene CNC-33.4%2025
Genmab GMAB16.5%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALC

Alcon, figure by figure

Alcon (ALC) overview: price, valuation and scorecardAll health care companies by market value

Alcon return on equity (ROE): questions and answers

What is Alcon's return on equity?

Alcon (ALC) earned a return on equity of 4.4% in fiscal 2025 (the year ended December 31, 2025). That is 0.3 percentage points lower than the 4.7% of fiscal 2024.

Is Alcon's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 14% of the 7 earlier fiscal years on record, whose median is 30.5%.

What are the highest and lowest return on equity figures on record for Alcon?

Across the 8 fiscal years on record (2007–2025), the highest was 47.0% in fiscal 2007 and the lowest 1.7% in fiscal 2022.

How is Alcon's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alcon (ALC) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ALC/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.